Basilea Pharmaceutica AG
BPMUF
$71.00
-$0.60-0.84%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 201.52M | 200.40M | 161.41M | 145.22M | 133.21M |
| Total Receivables | 79.80M | 79.36M | 72.08M | 64.85M | 64.21M |
| Inventory | 27.19M | 27.04M | 28.45M | 25.60M | 34.88M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 8.95M | 8.90M | 11.51M | 10.36M | 11.49M |
| Total Current Assets | 317.46M | 315.70M | 273.45M | 246.02M | 243.78M |
|
|
|||||
| Total Current Assets | 317.46M | 315.70M | 273.45M | 246.02M | 243.78M |
| Net Property, Plant & Equipment | 22.89M | 22.76M | 22.04M | 19.83M | 20.94M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 467.90K | 465.30K | 421.20K | 379.00K | 412.70K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 14.81M | 14.73M | 16.99M | 15.29M | 19.31M |
| Total Assets | 355.63M | 353.66M | 312.90M | 281.52M | 284.45M |
|
|
|||||
| Total Accounts Payable | 18.99M | 18.88M | 12.48M | 11.23M | 12.68M |
| Total Accrued Expenses | 30.14M | 29.97M | 20.41M | 18.36M | 23.73M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.60M | 2.59M | 2.59M | 2.33M | 2.28M |
| Total Finance Division Other Current Liabilities | 10.34M | 10.28M | 7.76M | 6.98M | 11.60M |
| Total Other Current Liabilities | 10.34M | 10.28M | 7.76M | 6.98M | 11.60M |
| Total Current Liabilities | 62.07M | 61.72M | 43.25M | 38.91M | 50.27M |
|
|
|||||
| Total Current Liabilities | 62.07M | 61.72M | 43.25M | 38.91M | 50.27M |
| Long-Term Debt | 95.14M | 94.61M | 103.09M | 92.75M | 105.84M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 14.77M | 14.69M | 16.02M | 14.41M | 15.12M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 22.31M | 22.18M | 20.84M | 18.75M | 23.83M |
| Total Liabilities | 194.28M | 193.21M | 183.19M | 164.82M | 195.07M |
|
|
|||||
| Common Stock & APIC | 1.34B | 1.34B | 1.34B | 1.20B | 1.17B |
| Retained Earnings | -1.11B | -1.11B | -1.14B | -1.03B | -1.02B |
| Treasury Stock & Other | -69.59M | -69.20M | -66.88M | -60.17M | -62.29M |
| Total Common Equity | 161.35M | 160.45M | 129.71M | 116.70M | 89.39M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 161.35M | 160.45M | 129.71M | 116.70M | 89.39M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 161.35M | 160.45M | 129.71M | 116.70M | 89.39M |
|
|
|||||